Nonproteolytic Polyubiquitin Chains at the Synapse

突触的非蛋白水解多聚泛素链

基本信息

  • 批准号:
    9001365
  • 负责人:
  • 金额:
    $ 40.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2020-02-29
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Altered assembly, function, and plasticity of synapses and neural circuits underlie cognitive, memory, and emotional deficits of essentially all neuropsychiatric and neurological diseases. A well-investigated mechanism that regulates synaptic protein turnover and synapse remodeling is the conventional ubiquitin-proteasome pathway, by which polyubiquitin chains conjugate to protein substrates (likely through lysine 48 (K48) of ubiquitin) and tag them for proteasomal degradation. A vastly overlooked ubiquitin modification in the central nervous system (CNS) is K63-linked polyubiquitination, an unconventional linkage mechanism generally believed not to target proteasomal degradation; rather, it regulates protein scaffolding, trafficking, and activity. Despite its recognized importace in cellular signaling mechanisms that mediate innate and adaptive immunity, virtually nothing is known about the role of this proteasome-independent polyubiquitination process in the CNS, especially synapses. Nonetheless, K63-linked ubiquitination is the second most abundant linkage in the rat brain, only slightly behind the K48 linkage. In addition, emerging evidence points to a link between K63-linked ubiquitination and a number of brain disorders. Thus, there is a need to investigate the mechanisms and roles of this nonproteolytic polyubiquitin topology in neurons and at synapse. Our preliminary studies indicate that K63-linked polyubiquitination is a fundamental mechanism regulating synapse assembly and plasticity and identify the postsynaptic scaffolding protein PSD-95 as the first substrate. We also identify a PSD-associated, K63-linkage-specific enzyme machinery that controls PSD-95 ubiquitination at synapses. The goals of this R01 application are to define the molecular details and functional consequences of PSD-95 K63 polyubiquitination (Aim 1), to delineate the role of K63 polyubiquitination in synapse development, function, remodeling, and plasticity (Aim 2), and to characterize the behavioral alterations in mice lacking K63-linkage-specific E3 ubiquitin ligase TRAF6 and deubiquitinase CYLD (Aim 3). A combination of molecular, biochemical, electrophysiological, and behavioral approaches will be employed. The proposed studies represent a fundamentally important conceptual breakthrough that opens up new avenues for investigation of synapse and circuit function and plasticity. The project has the potential to uncover new paradigm-shifting principles that govern neuro-immune interactions, which may contribute to abnormal brain wiring in neurodevelopmental disorders (such as schizophrenia and autism spectrum disorders) and neural circuit repair in the adult brain following injury. The information obtained will facilitate development of novel treatment strategies for these brain disorders.
 描述(由申请人提供):突触和神经回路的组装、功能和可塑性改变是基本上所有神经精神和神经系统疾病的认知、记忆和情感缺陷的基础。调节突触蛋白质周转和突触重塑的一个充分研究的机制是常规的泛素-蛋白酶体途径,通过该途径,多聚泛素链与蛋白质底物缀合(可能通过泛素的赖氨酸48(K48))并标记它们用于蛋白酶体降解。在中枢神经系统(CNS)中一个被极大忽视的泛素修饰是K63连接的多聚泛素化,这是一种非常规的连接机制,通常认为它不靶向蛋白酶体降解;相反,它调节蛋白质支架,运输和活性。尽管它在介导先天性和适应性免疫的细胞信号传导机制中的重要性已被公认,但实际上对这种蛋白酶体独立的多聚泛素化过程在CNS,特别是突触中的作用一无所知。尽管如此,K63连接的泛素化是大鼠大脑中第二丰富的连接,仅略低于K48连接。此外,新出现的证据表明K63相关的泛素化与许多大脑疾病之间存在联系。因此,有必要研究这种非蛋白水解的多聚泛素拓扑结构在神经元和突触中的机制和作用。我们的初步研究表明,K63连接的多泛素化是一个基本的机制,调节突触组装和可塑性,并确定突触后支架蛋白PSD-95作为第一底物。我们还确定了PSD相关的,K63连接特异性酶机制,控制PSD-95在突触泛素化。该R 01应用的目标是定义PSD-95 K63多聚遍在蛋白化的分子细节和功能后果(目标1),描述K63多聚遍在蛋白化在突触发育、功能、重塑和可塑性中的作用(目标2),并描述缺乏K63连接的小鼠的行为改变-特异性E3遍在蛋白连接酶TRAF 6和去遍在蛋白酶CYLD(目标3)。将采用分子、生物化学、电生理和行为方法的组合。这些研究代表了一个根本性的重要概念突破,为研究突触和电路功能以及可塑性开辟了新的途径。该项目有可能揭示新的范式转变原则,这些原则管理神经免疫相互作用,这可能有助于神经发育障碍(如精神分裂症和自闭症谱系障碍)中的异常大脑布线和损伤后成人大脑中的神经回路修复。所获得的信息将促进这些脑疾病的新的治疗策略的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wei-Dong Yao其他文献

Wei-Dong Yao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wei-Dong Yao', 18)}}的其他基金

Exploring the Pathogenicity of CYLD Variants in FTD
探索 CYLD 变异在 FTD 中的致病性
  • 批准号:
    10391941
  • 财政年份:
    2021
  • 资助金额:
    $ 40.69万
  • 项目类别:
CYLD in Synapse Pruning and Pathogenesis of FTD
CYLD 在突触修剪和 FTD 发病机制中的作用
  • 批准号:
    10419643
  • 财政年份:
    2021
  • 资助金额:
    $ 40.69万
  • 项目类别:
Nonproteolytic Polyubiquitin Chains at the Synapse
突触的非蛋白水解多聚泛素链
  • 批准号:
    9438416
  • 财政年份:
    2015
  • 资助金额:
    $ 40.69万
  • 项目类别:
PSD-95 REGULATION OF DOPAMINE RECEPTOR SIGNALING
PSD-95 多巴胺受体信号传导的调节
  • 批准号:
    8357929
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
FUNCTION AND PLASTICITY OF PREFRONTAL LOCAL CIRCUITS
额前局部回路的功能和可塑性
  • 批准号:
    8357975
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
MOLECULAR AND GENETIC ADAPTATIONS ASSOCIATED WITH COMPULSIVE COCAINE INTAKE
与强迫性可卡因摄入相关的分子和遗传适应
  • 批准号:
    8357952
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
DOPAMINERGIC MODULATION OF SYNAPTIC PLASTICITY IN THE PREFRONTAL CORTEX
前额皮质突触可塑性的多巴胺能调节
  • 批准号:
    8357944
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
Dopaminergic Enabling of Synaptic Plasticity in Prefrontal Circuits
前额叶回路中突触可塑性的多巴胺能启用
  • 批准号:
    8445321
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
NOVEL PSD MECHANISMS REGULATING SYNAPTIC DEVELOPMENT, FUNCTION, AND PLASTICITY
调节突触发育、功能和可塑性的新型 PSD 机制
  • 批准号:
    8357974
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:
Dopaminergic Enabling of Synaptic Plasticity in Prefrontal Circuits
前额叶回路中突触可塑性的多巴胺能启用
  • 批准号:
    8637960
  • 财政年份:
    2011
  • 资助金额:
    $ 40.69万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Research Grant
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Launchpad
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Collaborative R&D
Application name Phase Space - VR hypnotherapy as early intervention for anxiety in students and young people
应用程序名称 Phase Space - VR 催眠疗法作为学生和年轻人焦虑的早期干预
  • 批准号:
    10055011
  • 财政年份:
    2023
  • 资助金额:
    $ 40.69万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了